Latest Equities News

Askari Metals has addressed an ASX query regarding the late filing of a director's securities interest notice, attributing the delay to awaiting regulatory guidance following an inadvertent related party securities breach.

Aura Consolidated Group and Qoria Limited have announced a merger to create AXQ, a global leader in digital safety and cybersecurity, backed by a US$75 million equity raise and targeting strong growth and innovation.

Aura Consolidated Group Inc. is set to acquire Qoria Limited in a landmark $3 billion merger, creating a global leader in digital safety solutions with a new ASX listing under the ticker AXQ.

Apiam Animal Health shareholders have predominantly elected to receive scrip or mixed consideration in the proposed acquisition, with a special dividend of 10 cents per share proposed pending scheme approval.

Santa Fe Minerals has completed its acquisition of gold projects in Cote d’Ivoire from WIA Gold, issuing shares and performance rights as part of the deal. The company is now poised to advance exploration across its expanded portfolio.

Adelong Gold has finalised the sale of its remaining 49% interest in Challenger Mines to Great Divide Mining, receiving 10 million GDM shares and retaining a capped royalty on future gold production.

Bellavista Resources has announced a transformative acquisition of a 70% interest in the Pickle Crow Gold Project in Ontario, Canada, alongside a A$25 million equity raise to fund exploration and development.

Arcadia Minerals has secured a binding term sheet with Hongkong Xinhai Mining Services, granting Xinhai an exclusive option to advance the Swanson Tantalum Project in Namibia towards production through a strategic partnership and investment.

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

Brightstar Resources has successfully raised $180 million through a $175 million institutional placement and a $5 million share purchase plan, fully funding its Goldfields development and advancing the Sandstone project towards a final investment decision.

Orion Minerals has been selected for the prestigious 2026 BHP Xplor accelerator program, receiving US$500,000 in equity-free funding and access to BHP’s global expertise to advance its South African exploration projects.